论文部分内容阅读
追踪观察了已多次输血的血液肿瘤患者86次输用由白膜制备去白细胞的血小极浓缩物(BCPCs)的副反应和效果。 方法 输血小板指证:患者有出血或血小板数为15～20×10~9/L,用量通常为8.单位,用HLA不配合但ABO相容的随机供者。 第一次研究:患者33人,21人输用未去除过量白细胞的富含血小板血浆血小板浓缩物(PRPPCs),10人输用去白细胞的PRP PCs,2人输用了
Follow-up observation of side effects and effects of 86 transfusions of blood transfusions in patients with transplanted white blood cells (BCPCs) was performed on 86 white blood transfusions. Methods Platelets transfusion: Patients with bleeding or platelet number 15 ~ 20 × 10 ~ 9 / L, the amount is usually 8. Unit, with HLA does not match but ABO-compatible random donor. In the first study, 33 patients, 21 were transfused with platelet-rich plasma platelet concentrates (PRPPCs) that did not remove excess leukocytes, 10 were transfused with leukocyte-depleted PRP PCs and 2 were used